IGNE Igene Biotechnology Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IGNE Igene Biotechnology

IGNE 0.00001000

0.0%

Mar 6 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Dwayne Hines	2/17/2007 11:58:53 PM
	of 209

Interesting triangle - Tate & Lyle, Igene, Microbia: The Microbia subsidiary is developing microbes to aid in a fermentation-based process of making carotenoids, a family of compounds responsible for the pink color of salmon meat and the orange in carrots. He estimated that the U.S. market for manufactured carotenoids, which are well-known antioxidants, is $1 billion. "The bottom line is there is a lot of optimism right now ... for fermentation-based processes to displace a number of (ingredients) that are now based on oil and petro-based chemicals," said Bailey, a microbial physiologist who joined Microbia nearly five years ago after working in senior positions at St. Louis-based Monsanto Co.'s NutraSweet Kelco unit and Broomfield, Colo.-based startup ZeaGen Inc. In addition to needed capital, Tate & Lyle provides Microbia PE with the backing of a $4.65 billion corporation with 17 fermentation plants spread over four continents. source - bizjournals.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next